Skip to content

Impact of Exercise Training on Endothelial Function in CAD

Impact of Exercise Training on Bradykinin-Mediated Endothelial Function in Patients With Coronary Artery Disease

Status
UNKNOWN
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00176345
Enrollment
20
Registered
2005-09-15
Start date
2001-01-31
Completion date
Unknown
Last updated
2005-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary Artery Disease

Keywords

exercise training, endothelial function

Brief summary

Bradykinin has been identified to contribute to the release of nitric oxide (NO), prostacyclin, and EDHF through activation of specific bradykinin 2 (B2) receptors, which is finally promoting a vasodilatory respone. Regular physical exercise training results in an improvement of endothelial function in patients with CAD. These positive effects were partially attributed to an increased expression of endothelial NO synthase (eNOS) and cyclooxygenase (COX) as a result of the training intervention. Aim of this trial is therefore to determine, whether the training-induced correction of endothelial dysfunction is also bradykinin-dependent.

Detailed description

A total of 20 patients with stable coronary artery disease are prospectively randomized to 4 weeks of exercise training or sedentary lifestyle. Endothelial function of the radial artery is determined by a high-resolution A-mode ultrasound.

Interventions

BEHAVIORALExercise Training

Sponsors

University of Leipzig
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
ECT
Masking
NONE

Eligibility

Sex/Gender
MALE
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* stable CAD * male gender

Exclusion criteria

* insulin-dependent diabetes mellitus * significant valvular heart disease * smoking * exercise-induced myocardial ischemia * conditions prohibiting exercise training

Design outcomes

Primary

MeasureTime frame
Endothelial function

Countries

Germany

Contacts

Primary ContactRainer P Hambrecht, MD
hamr@medizin.uni-leipzig.de++49-341 865
Backup ContactSandra Erbs, MD
Sandra.Erbs@medizin.uni-leipzig.de++49-341 865

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026